Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$10.25
+2.30%
Mkt Cap $1.60B
Analyst Ratings
Buy
1
Hold
1
Sell
1
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+75.6%
Consensus $18.00 vs current $10.25
NASDAQ·Healthcare·Biotechnology
$10.25
+2.30%
Mkt Cap $1.60B
Buy
1
Hold
1
Sell
1
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+75.6%
Consensus $18.00 vs current $10.25